Europe: ProteoMedix Prepping Prostate Cancer IVD for Market Launch

Europe In-depth news and analysis on the European life science market

Recent European Headlines premium ProteoMedix Prepping Prostate Cancer IVD for Market Launch Published on Dec 07, 2018 free HiberGene Gets CE Mark for Rapid Flu Combo MDx Published on Dec 13, 2018 free Curetis to Cut 30 Percent of Workforce as Part of Strategic Restructuring Published on Dec 13, 2018 free PredictImmune Wins £100K Grant for Study of IBD Prognostic Published on Dec 13, 2018 free Diagnostics Firm Quotient Nets $64.6M From Public Offering Published on Dec 11, 2018 free Novacyt to Sell Cytology, Clinical Lab Units Published on Dec 11, 2018 free PredictImmune Gains CE-IVD Mark for IBD Test Published on Dec 11, 2018 free AusDiagnostics Hemochromatosis MDx Receives CE-IVD Mark Published on Dec 10, 2018 free Oxford Immunotec Gets China FDA Approval for TB Reagent Kit Published on Dec 07, 2018 Most Read Stories in Europe premium Live Cell Phenotyping Test Predicts Prostate Cancer Pathology with High Precision Published on Dec 13, 2018 premium InterVenn Aims to Push Glycoproteomics Into the Clinic Published on Dec 13, 2018 free Guardant Health to Develop Blood-Based CDx for AstraZeneca Drugs Published on Dec 13, 2018 free Sonic Healthcare to Acquire Anatomical Pathology Provider Aurora Diagnostics Published on Dec 13, 2018